24.35
price up icon1.97%   0.47
after-market アフターアワーズ: 24.35
loading
前日終値:
$23.88
開ける:
$23.89
24時間の取引高:
952.99K
Relative Volume:
1.12
時価総額:
$2.10B
収益:
$23.38M
当期純損益:
$-155.22M
株価収益率:
-11.12
EPS:
-2.19
ネットキャッシュフロー:
$-134.36M
1週間 パフォーマンス:
+3.09%
1か月 パフォーマンス:
-5.25%
6か月 パフォーマンス:
-43.44%
1年 パフォーマンス:
-44.06%
1日の値動き範囲:
Value
$23.88
$24.97
1週間の範囲:
Value
$23.34
$24.97
52週間の値動き範囲:
Value
$22.10
$47.73

Ideaya Biosciences Inc Stock (IDYA) Company Profile

Name
名前
Ideaya Biosciences Inc
Name
セクター
Healthcare (1173)
Name
電話
650-443-6209
Name
住所
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
職員
124
Name
Twitter
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
IDYA's Discussions on Twitter

IDYA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IDYA
Ideaya Biosciences Inc
24.35 2.10B 23.38M -155.22M -134.36M -2.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
461.68 118.90B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
672.98 73.95B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
655.13 39.81B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
271.31 34.99B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
123.77 29.67B 3.30B -501.07M 1.03B -2.1146

Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-18 開始されました Stephens Overweight
2024-11-05 ダウングレード Leerink Partners Outperform → Market Perform
2024-10-24 開始されました UBS Buy
2024-10-15 開始されました Cantor Fitzgerald Overweight
2024-07-08 開始されました Mizuho Outperform
2024-03-08 開始されました BTIG Research Buy
2023-08-08 開始されました SVB Securities Outperform
2023-05-24 開始されました Goldman Buy
2023-04-24 アップグレード Stifel Hold → Buy
2023-03-23 開始されました Berenberg Buy
2023-02-28 開始されました RBC Capital Mkts Outperform
2022-12-28 開始されました CapitalOne Overweight
2022-10-27 開始されました Citigroup Buy
2022-08-15 ダウングレード Stifel Buy → Hold
2022-07-18 再開されました Oppenheimer Outperform
2022-03-10 アップグレード Stifel Hold → Buy
2021-09-23 開始されました Stifel Hold
2021-06-04 再開されました Robert W. Baird Outperform
2021-03-11 開始されました Guggenheim Buy
2020-10-07 開始されました Wedbush Outperform
2020-09-01 開始されました Northland Capital Outperform
2020-07-13 アップグレード JP Morgan Neutral → Overweight
2020-06-17 繰り返されました H.C. Wainwright Buy
2020-04-06 開始されました H.C. Wainwright Buy
2020-03-13 開始されました ROTH Capital Buy
2019-10-17 開始されました Oppenheimer Outperform
2019-09-10 開始されました Robert W. Baird Outperform
2019-06-17 開始されました Citigroup Buy
2019-06-17 開始されました JP Morgan Neutral
2019-06-17 開始されました Jefferies Buy
すべてを表示

Ideaya Biosciences Inc (IDYA) 最新ニュース

pulisher
Feb 01, 2025

IDYAIDEAYA Biosciences, Inc. Latest Stock News & Market Updates - StockTitan

Feb 01, 2025
pulisher
Jan 31, 2025

IDEAYA Awards Strategic Stock Options Package: Key Details for New Hires Revealed - StockTitan

Jan 31, 2025
pulisher
Jan 30, 2025

12 Stocks That Will Double in 2025 - Insider Monkey

Jan 30, 2025
pulisher
Jan 30, 2025

Uncover the Top 12 Stocks Set to Skyrocket by 2025! - Reporteros del Sur -

Jan 30, 2025
pulisher
Jan 30, 2025

Here’s Why IDEAYA Biosciences, Inc. (IDYA) Will Double in 2025 - Insider Monkey

Jan 30, 2025
pulisher
Jan 28, 2025

BTIG reiterates Buy on Ideaya stock, cites significant updates - MSN

Jan 28, 2025
pulisher
Jan 27, 2025

Mizuho Initiates Coverage of IDEAYA Biosciences (IDYA) with Outperform Recommendation - MSN

Jan 27, 2025
pulisher
Jan 27, 2025

IDEAYA Biosciences to Participate in Upcoming February 2025 Investor Relations Events - Nasdaq

Jan 27, 2025
pulisher
Jan 27, 2025

IDEAYA Biosciences to Present at Major Healthcare Investment Conferences - StockTitan

Jan 27, 2025
pulisher
Jan 26, 2025

(IDYA) Technical Data - Stock Traders Daily

Jan 26, 2025
pulisher
Jan 26, 2025

Here's Why We're Not Too Worried About IDEAYA Biosciences' (NASDAQ:IDYA) Cash Burn Situation - Yahoo Finance

Jan 26, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Weighs in on IDYA FY2025 Earnings - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

Brokers Issue Forecasts for IDYA FY2025 Earnings - MarketBeat

Jan 22, 2025
pulisher
Jan 21, 2025

BTIG reiterates Buy on Ideaya stock, cites significant updates By Investing.com - Investing.com Canada

Jan 21, 2025
pulisher
Jan 21, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Stock Holdings Lifted by JPMorgan Chase & Co. - Defense World

Jan 21, 2025
pulisher
Jan 21, 2025

JPMorgan Chase & Co. Grows Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

Ideaya stock touches 52-week low at $22.15 amid market challenges - MSN

Jan 21, 2025
pulisher
Jan 20, 2025

Short Interest in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Expands By 10.1% - MarketBeat

Jan 20, 2025
pulisher
Jan 19, 2025

IDEAYA Biosciences (IDYA): A Down Year Presents a Window of Opportunity for Investors - MSN

Jan 19, 2025
pulisher
Jan 18, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Hits New 1-Year LowHere's Why - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

IDEAYA Biosciences’ (IDYA) “Outperform” Rating Reiterated at Royal Bank of Canada - Defense World

Jan 18, 2025
pulisher
Jan 17, 2025

Ideaya stock touches 52-week low at $22.15 amid market challenges By Investing.com - Investing.com South Africa

Jan 17, 2025
pulisher
Jan 17, 2025

Leerink Partners Downgrades IDEAYA Biosciences (IDYA) - MSN

Jan 17, 2025
pulisher
Jan 15, 2025

Learn to Evaluate (IDYA) using the Charts - Stock Traders Daily

Jan 15, 2025
pulisher
Jan 15, 2025

Royal Bank of Canada Reaffirms "Outperform" Rating for IDEAYA Biosciences (NASDAQ:IDYA) - MarketBeat

Jan 15, 2025
pulisher
Jan 14, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Given “Overweight” Rating at Cantor Fitzgerald - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance - The Malaysian Reserve

Jan 13, 2025
pulisher
Jan 12, 2025

IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance – Company Announcement - Financial Times

Jan 12, 2025
pulisher
Jan 12, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Hits New 12-Month Low – Here’s Why - Defense World

Jan 12, 2025
pulisher
Jan 10, 2025

Ideaya Biosciences stock hits 52-week low at $24.14 By Investing.com - Investing.com Australia

Jan 10, 2025
pulisher
Jan 10, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Reaches New 1-Year LowShould You Sell? - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Ideaya Biosciences stock hits 52-week low at $24.14 - Investing.com

Jan 10, 2025
pulisher
Jan 10, 2025

Analysts Set IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Price Target at $53.67 - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jan 10, 2025
pulisher
Jan 07, 2025

IDEAYA Biosciences' SWOT analysis: oncology biotech stock's potential and risks - Investing.com Australia

Jan 07, 2025
pulisher
Jan 07, 2025

IDEAYA Biosciences' SWOT analysis: oncology biotech stock's potential and risks By Investing.com - Investing.com South Africa

Jan 07, 2025
pulisher
Jan 07, 2025

Principal Financial Group Inc. Sells 4,968 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jan 07, 2025
pulisher
Jan 03, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Jan 03, 2025
pulisher
Jan 03, 2025

Another Major DLL3 ADC Alliance As Hengrui Links With IDEAYA - News & Insights

Jan 03, 2025
pulisher
Jan 02, 2025

Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals - BioPharma Dive

Jan 02, 2025
pulisher
Jan 02, 2025

IDEAYA Biosciences in-licenses Hengrui’s SHR-4849 - The Pharma Letter

Jan 02, 2025
pulisher
Dec 31, 2024

Ideaya, Hengrui join hands in $1B deal for phase I ADC targeting DLL3 - BioWorld Online

Dec 31, 2024
pulisher
Dec 31, 2024

IDEAYA Biosciences Enters into Exclusive License Agreement with Hengrui Pharma - Defense World

Dec 31, 2024
pulisher
Dec 30, 2024

IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors - Kilgore News Herald

Dec 30, 2024
pulisher
Dec 30, 2024

Ideaya Biosciences stock hits 52-week low at $24.38 By Investing.com - Investing.com Nigeria

Dec 30, 2024

Ideaya Biosciences Inc (IDYA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
大文字化:     |  ボリューム (24 時間):